论文部分内容阅读
最新研究结果显示,在发生慢性排斥的肺移植鼠模型中,联合应用供体特异性输注技术(DST)和抗CD154单克隆抗体治疗可诱导其对移植器官的长期耐受。来自于美国北卡罗来纳州立大学的Robert M．Aris博士及其同事在接受路透健康记者的电话采
The latest findings show that long-term tolerance to transplanted organs can be induced by a combination of donor-specific infusion (DST) and anti-CD154 monoclonal antibody therapy in a rat model of chronic rejection of lung transplantation. Robert M from North Carolina State University, USA Dr. Aris and colleagues are receiving phone calls from Reuters Health reporters